Yahoo Web Search

Search results

1. • NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results

     Morningstar· 2 days ago

     Global licensing, co-development, and commercialization agreement with Janssen Pharmaceutica NV (“Janssen”) expands worldwide potential ...

2. • 

     Nanobiotix reports progress and financial results for 2023 By Investing.com

     Investing.com· 2 days ago

     The company highlighted the expansion of its radioenhancer NBTXR3's global potential through a...

3. • Essential Pharma Announces the Acquisition of Reminyl® (galantamine hydrobromide) Oral Capsules

     Morningstar· 1 week ago

     Essential Pharma Announces the Acquisition of Reminyl® (galantamine hydrobromide) Oral Capsules Reminyl® is an established CNS brand for the symptomatic treatment of mild to moderately severe ...